SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-064229
Filing Date
2024-05-23
Accepted
2024-05-23 19:27:41
Documents
1
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3871
  Complete submission text file 0000950170-24-064229.txt   5317
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Gross Jane A (Reporting) CIK: 0001684258 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 24980372